BREZTRI AEROSPHERE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jul 23, 2020

   6 yr ago

2. Today

3. Patent 10716753 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

4. Patent 8324266 expires

   Listed method-of-use patent (U-2889) expiration.

   May 28, 2030

   in 4 yr

5. Patent 8703806 expires

   Listed method-of-use patent (U-2889) expiration.

   May 28, 2030

   in 4 yr

6. Patent 8808713 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

7. Patent 9415009 expires

   Listed method-of-use patent (U-2889) expiration.

   May 28, 2030

   in 4 yr

8. Patent 9463161 expires

   Listed drug product patent expiration.

   May 28, 2030

   in 4 yr

9. Patent 8815258 expires

   Listed method-of-use patent (U-2889) expiration.

   Mar 17, 2031

   in 4 yr 10 mo

10. Patent 11331442 expires

    Listed drug product patent expiration.

    Oct 05, 2038

    in 12 yr 6 mo

11. Patent 11833292 expires

    Listed drug product patent expiration.

    Oct 05, 2038

    in 12 yr 6 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (9)